Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
10/2012
10/26/2012WO2012143413A1 Tetrahydroquinoline derivatives useful as bromodomain inhibitors
10/26/2012WO2012143320A1 (7h-pyrrolo[2,3-d]pyrimidin-2-yl)amine compounds as jak3 inhibitors
10/26/2012WO2012143144A1 Pyrazolo [4, 3-d] pyrimidines useful as kinase inhibitors
10/26/2012WO2012143143A1 Heterocyclic compounds as kinase inhibitors
10/26/2012WO2012143041A1 Composition, method for its manufacture and use thereof
10/26/2012WO2012142696A1 Locally-active anticoagulants and anti-inflammatory agents
10/26/2012WO2012092160A3 Neutral human milk oligosaccharides to promote growth of beneficial bacteria
10/26/2012WO2012082718A3 3-methanesulfonylpropionitrile for treating inflammation and pain
10/26/2012CA2833614A1 Locally-active anticoagulants and anti-inflammatory agents
10/26/2012CA2832763A1 Tetrahydroquinoline derivatives useful as bromodomain inhibitors
10/26/2012CA2831680A1 Heterocyclic compounds as kinase inhibitors
10/26/2012CA2831634A1 Pyrazolo [4,3-d] pyrimidines useful as kinase inhibitors
10/25/2012US20120271361 Functionalized Nanodiamond Reinforced Biopolymers
10/25/2012US20120270955 Ophthalmic composition with a viscosity enhancement system having two different viscosity enhancing agents
10/25/2012US20120270954 Methods for maintaining eye health and ameliorating opthalmic maladies in canines
10/25/2012US20120270951 Novel anti-inflammatory cyclooxygenase inhibitors
10/25/2012US20120270939 Formulations and methods for treating amyloidosis
10/25/2012US20120270936 Composition and method for treatment of inflamation and infections of the genitalia, contraceptive and the prophylaxis of sexually transmitted diseases
10/25/2012US20120270924 Oligomeric Compounds For The Modultion of HIF-1A Expression
10/25/2012US20120270922 Antiangiogenic Agent and Method for Inhibition of Angiogenesis
10/25/2012US20120270920 Compositions and methods for treatment of pouchitis
10/25/2012US20120270916 Topical formulations for treating neuropathy
10/25/2012US20120270907 Therapeutic uses of nicotine
10/25/2012US20120270906 Cyclohexane derivative and pharmaceutical use thereof
10/25/2012US20120270901 Indene derivatives as pharmaceutical agents
10/25/2012US20120270899 Compositions and Methods for Treating Cardiovascular Diseases
10/25/2012US20120270897 Acetylene derivatives of 5-phenyl-pyrazolopyridine, preparation thereof, and therapeutic use thereof
10/25/2012US20120270892 Aminopyrimidine Kinase Inhibitors
10/25/2012US20120270881 Conformationally constrained, fully synthetic macrocyclic compounds
10/25/2012US20120270879 Heterocyclic Compounds As CCR1 Receptor Antagonists
10/25/2012US20120270878 Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
10/25/2012US20120270876 Treatment of Conditions Through Pharmacological Modulation of the Autonomic Nervous System
10/25/2012US20120270873 Adamantyl diamide derivatives and uses of same
10/25/2012US20120270870 Indazole and Pyrazolopyridine Compounds As CCR1 Receptor Antagonists
10/25/2012US20120270868 Rho kinase inhibitors
10/25/2012US20120270863 Fused ring analogues of anti-fibrotic agents
10/25/2012US20120270862 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
10/25/2012US20120270859 Indoline derivatives and their use in treating disease-states such as cancer
10/25/2012US20120270857 5-ht3 receptor modulators, methods of making, and use thereof
10/25/2012US20120270855 Thieno- and furo-pyrimidine modulators of the histamine h4 receptor
10/25/2012US20120270846 Preparation of an acetyl salicylic acid/glutamic acid complex for oral administration
10/25/2012US20120270845 Compositions and Methods for Treating Chronic Inflammation and Inflammatory Diseases
10/25/2012US20120270837 Compositions that treat or inhibit pathological conditions associated with inflammatory response
10/25/2012US20120270835 Medicinal Cream Made Using Hydrocortisone Acetate and A Process To Make The Same
10/25/2012US20120270829 Use of adenosine a3 receptor agonists for treatment of neuropathic pain
10/25/2012US20120270825 Salix extract, its use and formulations containing it
10/25/2012US20120270821 CDK5 Inhibitors and Therapeutic Uses Thereof
10/25/2012US20120270796 Suspension Type Topical Formulations Comprising Cyclic Depsipeptide
10/25/2012US20120270792 Urocortin-iii and uses thereof
10/25/2012US20120270787 Compounds having peptides conjugated to bone targeting moieties and methods of making and using thereof
10/25/2012US20120270770 Anti-angiogenic peptides and their uses
10/25/2012US20120270769 Methods of using macrocyclic inhibitors of serine protease enzymes
10/25/2012US20120269913 Crude caffeine complex, improved food products using the crude caffeine complex, and methods of use thereof
10/25/2012US20120269912 Compositions and methods of treatment that include plant extracts
10/25/2012US20120269903 Novel mannopyranoside derivatives with anticancer activity
10/25/2012US20120269891 Controlled release oral pharmaceutical dosage forms comprising mgbg
10/25/2012US20120269882 Brain Delivery of Insulin to Treat Systemic Inflammation
10/25/2012US20120269881 Transdermal drug delivery device including an occlusive backing
10/25/2012US20120269880 Purified amniotic membrane compositions and methods of use
10/25/2012US20120269878 Composition For Transdermal Delivery Of Fentanyl
10/25/2012US20120269866 Gastroretentive Composition On The Basis Of A Water-Soluble Reaction Product From A Vinyl Group-Containing Precursor
10/25/2012US20120269865 Nutritional composition for promoting gut microbiota balance and health
10/25/2012US20120269838 Carrier conjugates of il-23-peptides and their induced antibodies
10/25/2012US20120269834 Immunoglobulin cleavage fragment vaccine compositions
10/25/2012US20120269824 Therapeutic human anti-il-1r1 monoclonal antibody
10/25/2012US20120269820 Anti-il 17a/il-17f cross-reactive antibodies and methods of use thereof
10/25/2012US20120269819 Human Anti-IFN-gamma Neutralizing Antibodies as Selective IFN-gamma Pathway Inhibitors
10/25/2012US20120269808 Methods and compositions for modulating tweak and fn14 activity
10/25/2012US20120269804 Substituted benzosulphonamides
10/25/2012US20120269803 Substituted benzosulphonamides
10/25/2012US20120269799 Diagnostic and treatment methods using a ligand library
10/25/2012US20120269797 Method for inhibiting the maturation of dendritic cells
10/25/2012US20120269789 Growing up milks containing probiotic micro-organisms
10/25/2012US20120269787 Systemic, allogenic stem cell therapies for treatment of diseases in equines
10/25/2012US20120269786 Systemic, allogenic stem cell therapies for treatment of diseases in felines
10/25/2012US20120269785 Systemic, allogenic stem cell therapies for treatment of diseases in canines
10/25/2012US20120269783 Composition containing autologous mononuclear cells and pig collagen scaffold in paste form and its use in the preparation of a medicament for surgical treatment
10/25/2012US20120269765 Cytokine compositions and methods of use thereof
10/25/2012US20120269763 Compositions and methods for reducing the risk of preterm labor
10/25/2012US20120269733 Model Systems and Treatment Regimes for Treatment of Neurological Disease
10/25/2012US20120269726 Heterodimers of Glutamic Acid
10/24/2012EP2514752A1 Epothilone compounds, preparation method and use thereof
10/24/2012EP2514751A1 Azaindazoles useful as inhibitor of kinases
10/24/2012EP2514743A1 Immunosuppressant Compounds and Compositions
10/24/2012EP2514440A1 Transdermal preparation containing basic anti-inflammatory agent
10/24/2012EP2514426A1 Compounds having anti-inflammatory activity
10/24/2012EP2514425A1 Composition containing protopanaxatriol and protopanaxadiol
10/24/2012EP2514424A1 Piroxicam-containing endermic preparation
10/24/2012EP2514419A1 Felbinac-containing transdermal absorption preparation
10/24/2012EP2514409A1 Topical pharmaceutical compositions of nimesulide and methylsulfonylmethane
10/24/2012EP2513343A1 Methods and compositions for treating inflammation of skin
10/24/2012EP2513114A1 Pyrrolo[2,3-d]pyrimidine compounds
10/24/2012EP2513111A1 Mk2 inhibitors
10/24/2012EP2513098A1 Aminopyrimidines as syk inhibitors
10/24/2012EP2513093A1 New ccr2 receptor antagonists and uses thereof
10/24/2012EP2513086A1 Novel antagonists for ccr2 and uses thereof
10/24/2012EP2513068A1 Substituted benzothiazole and benzoxazole derivatives useful as inhibitors of dpp-1
10/24/2012EP2513057A1 Sphingosine kinase inhibitors
10/24/2012EP2512505A2 Modified clostridial toxins comprising an integrated protease cleavage site-binding domain
10/24/2012EP2512504A1 Treatment composition and method
1 ... 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 ... 1272